The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Pellini, Managing Partner of Section 32 (former CEO of Foundation Medicine), and in essence is a repost of the original interview...read more
Latest blogs
Basepair Provides an Intuitive, Easy-to-Use NGS Data Analysis Platform Which Does Not Require Coding Skills
This month’s Company Spotlight provides a closer look at Basepair, a developer and supplier of a suite of automated NGS analysis solutions for research, clinical, and pharma teams. The company’s mission is to provide an...read more
Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases
This month’s “Company Spotlight” takes a closer look at Othram Inc which applies the power of modern sequencing technology and genomics to forensics. David Mittelman, Chief Executive Officer of Othram, discussed with us...read more
BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More
The 18th installment of Boston’s Bio-IT World Conference was attended by over 3,400 participants and featured more than 185 exhibiting companies, both established and startups. The conference program kicked off with a...read more
Sentieon Solves Complex Mathematical Problems – Applied to DNA Sequence Secondary Data Analysis – by Enhancing them With Extreme Accuracy and Efficiency
This month’s “Company Spotlight” provides a closer look at Sentieon, a developer and supplier of a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast...read more
AGBT 2019, And the Winners are “Spatial Genomics, Single-cell Genomics, and Long-read Sequencing”
For the first time in three years AGBT returned to Marco Island for its 2019 conference. It was pleasant to be back and be able to enjoy the warmth and the friendly setting we’ve all remembered. The weather played along...read more
JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …
As we all know the JP Morgan Healthcare conference is an invitation-only conference. For this reason, I have summarized various announcements for the purpose of this review. As we have witnessed in the past, exciting...read more
